FDA Warns Homeopathic Earache Products About Rx Claims
This article was originally published in The Tan Sheet
Executive Summary
The products are indicated for “treatment of ear pain or inflammation,” a condition that must be treated by a doctor, the agency says in warning letters that cite the ear drops for misbranding. FDA warns Murine, Auro, TopCare brands and says additional warnings to homeopathic product makers could come.
You may also be interested in...
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.
Drug Safety In Pregnant Women: FDA Seeks Alternatives To Registries
Stakeholder meeting will address poor enrollment rates and other issues that undermine the utility of pregnancy registries, as well as the use of alternatives, such as case control studies and claims-based database studies.